Arcutis Names Rob Lisicki Chief Commercial Officer

PUBT · 1d ago
Arcutis Names Rob Lisicki Chief Commercial Officer
  • Arcutis appointed Rob Lisicki chief commercial officer effective November 4, 2026. Lisicki has over 30 years of biopharmaceutical industry experience.
  • Rob Scott, MD, joined the board of directors in October 2026. Scott is a global pharmaceutical industry leader.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.